Jergensen Joshua sold $1.8M of PACS

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $45.02 ($44.50–$45.76, $1.80M total) across 3 trades on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jergensen Joshua
Published Jul 16, 2026, 10:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PACS
Neutral
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSNeutralLow
01

Why it matters

The newest fact is the COO’s $1.8M open-market sale of 40,000 shares at $44.4983 to $45.7585, executed under a 10b5-1 plan.

02

Market read

This provides a concrete, dated insider-sale datapoint, but it is not tied to new operational or financial disclosures.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or fundamentals, the signal is usually secondary.

Relevance 5/10Novelty 5/10Timing: after-hours, SEC Form 4 filed 2026-07-16 for a 2026-07-15 sale

Background

The article is an SEC Form 4 insider transaction disclosure for PACS Group, Inc.

Company-level read

Ticker impact

$PACSNeutralMedium confidence
Context

PACS Group COO sold $1.8M of PACS shares in an open-market transaction under a pre-arranged 10b5-1 plan on 2026-07-15.

Expected impact

Likely limited near-term price impact; any effect should be small and sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure with transaction size and pricing, but it is explicitly under a pre-arranged 10b5-1 plan, which typically dampens inference about new information.

Market effects

No sector-level implications; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • PACS Group, Inc.

    Subject of the Form 4 insider sale by its President and COO.

  • Jergensen Joshua

    President and COO who sold shares totaling about $1.8M under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.